CLINICALLY PROVEN1 ( MOIZ CLEANSING LOTION ):
| 100% | Subjects showed complete absence of dryness by Day 15 |
| 85% | Porphyrin size reduced |
| 118% | Overall skin tone improved |
Deeply cleanses your skin, removing dirt, sweat, dead skin cells, impurities, and makeup, while maintaining your skin's delicate barrier. Leaves your skin feeling soft and supple.
Moiz Cleansing Lotion is expertly formulated to help unclog pores and balance natural sebum production for a more vibrant, and radiant skin.
Dermatologically Tested & Non-Irritant2
Refrences:
1As per Clinical Safety & Efficacy Study NB240043-GL | CSR NB240043-GL|24|060, Jan 2025
2As per HRIPT Dermatological Evaluation Study, D01-6Q01-WO-JE23, Oct 2023
CLINICALLY PROVEN (SEBONAC FACE WASH):
Refresh and rebalance your skin with Sebonac Face Wash, designed to fight acne, excess oil, and clogged pores without stripping moisture. 1% Glycolic Acid gently exfoliates to reveal smoother, brighter skin, while Aloe Vera and Allantoin soothe and support recovery. Enriched with Vitamin E, it helps protect against environmental damage for clear, calm, and healthy-looking skin with every wash.
Suitable for sensitive skin, Dermatologist-tested, Non-irritant and Hypo-allergenic1
Refrences:
1As per HRIPT Clinical Study Report, RRS/CL/HRIPT/002/2023, Aug 2023.
CLINICALLY PROVEN1 (MOIZ MM SKIN BARRIER RESTORING CREAM):
To improve hydration by 163% on barrier-damaged skin.
Moiz MM Barrier Restoring Cream provides Maximum Moisturization to revitalize skin barrier function, help reduce irritation, roughness, and tightness of skin.
Dermatologically Tested2, non-comedogenic formula is free from parabens and sulfates. Contains IFRA-Certified fragrance, is non-greasy, and non-sticky.
A powerhouse blend featuring 9 powerful moisturizers including Shea Butter (for skin nourishment), Silkflo® 366 (moisturizes with unique non-oily feel) and Glycerin (draws moisture into the skin) to help hydrate, soften, soothe, and protect sensitive skin.
Refrences:
1As per Clinical Safety & Efficacy Study NB240044-GL | CSR NB240044-GL|25|010, Apr 2025.
2As per HRIPT Dermatological Evaluation Study, D01-6Q01-WO-JE23, Oct 2023.